ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
January 06 2025 - 3:05PM
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman
and chief executive officer, and Dr. Carlos Nunez, chief medical
officer, will present at the 43rd Annual J.P. Morgan Healthcare
Conference on Monday, January 13, 2025, beginning at approximately
3:00 p.m. (Pacific Standard Time) in San Francisco, CA.
More information about this event, including access to the live,
audio-only webcast, may be accessed by visiting
https://investor.resmed.com. The audio-only webcast replay will be
available approximately 24 hours after the live webcast ends and
will be accessible for the following thirty (30) days.
About ResMedAt ResMed (NYSE: RMD, ASX: RMD) we
pioneer innovative solutions that treat and keep people out of the
hospital, empowering them to live healthier, higher-quality lives.
Our digital health technologies and cloud-connected medical devices
transform care for people with sleep apnea, COPD, and other chronic
diseases. Our comprehensive out-of-hospital software platforms
support the professionals and caregivers who help people stay
healthy in the home or care setting of their choice. By enabling
better care, we improve quality of life, reduce the impact of
chronic disease, and lower costs for consumers and healthcare
systems in more than 140 countries. To learn more, visit
ResMed.com and follow @ResMed.
For investors |
For media |
+1 858.836.5000 |
+1 619.510.1281 |
investorrelations@resmed.com |
news@resmed.com |
ResMed (NYSE:RMD)
Historical Stock Chart
From Dec 2024 to Jan 2025
ResMed (NYSE:RMD)
Historical Stock Chart
From Jan 2024 to Jan 2025